4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-026231
SVP and General Counsel sold 19,580 shares at $30.22 ($591,708)
- SVP and General Counsel acquired 19,580 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-04-27 | Option exercise | +8,310 | $7.80 | $64,818 | 9,610 | D |
| Taylor Stacy L SVP and General Counsel | 2020-04-27 | Option exercise | +11,270 | $6.55 | $73,819 | 20,880 | D |
| Taylor Stacy L SVP and General Counsel | 2020-04-27 | Sale | −19,580 | $30.22 | $591,708 | 1,300 | D |
| Derivatives | |||||||
| Taylor Stacy L SVP and General Counsel | 2020-04-27 | Option exercise · Stock Option (Right to Buy) | −8,310 | 41,690 | D | ||
| Taylor Stacy L SVP and General Counsel | 2020-04-27 | Option exercise · Stock Option (Right to Buy) | −11,270 | 40,730 | D | ||
| Open-market sales · 19,580 sh · avg $30.22 · $591,708 | |||||||
Loading xslF345X03/doc4.xml…